Cover Image
Market Research Report
Product code 
1070504

Stem Cell Banking Market by Service Type, Utilization, Cell Type, and Bank Type : Global Opportunity Analysis and Industry Forecast, 2021-2030

Published: | Allied Market Research | 220 Pages | Delivery time: 2-3 business days

Price

Back to Top
Stem Cell Banking Market by Service Type, Utilization, Cell Type, and Bank Type : Global Opportunity Analysis and Industry Forecast, 2021-2030
Published: February 3, 2022
Allied Market Research
Content info: 220 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global stem cell banking market was valued at $4,298.5 million in 2020, and is projected to reach $16,558.4 million by 2030, registering a CAGR of 15.6% from 2021 to 2030.

Stem cell banking is the process of procuring precious stem cells from human body, processing and storing them for potential future use in stem cell treatments. Stem cell banks use low temperatures to preserve the biological properties of stem cells, protect them from contamination and degeneration. Standardized and quality controlled preservative procedures are required for any stem cell bank in order to preserve the cells for longer periods of time without losing their properties.

Rise in number of births occurring globally, increase in R&D activities in regards with applications of stem cells, and surge in prevalence of fatal chronic diseases drive the growth of the market. In addition, stem cells are used for various types of cancers and blood related diseases. For instance, according to the Journal of Leukemia & lymphoma society's report, in 2021, it was estimated that around 186,400 populations in the U.S. are diagnosed with leukemia, lymphoma, or myeloma. The rise in disposable income globally is projected to help increase the number of stem cell units stored, which in turn boosts the market growth.

Furthermore, surge in demand for advanced treatment for serious diseases boosts market growth. The rise in number of stem cell banks and increase in health expenditure of peoples further contribute in market growth.

The stem cell banking market is segmented on the basis of service type, utilization, cell type, bank type, and region. By service type, the market is mainly categorized into collection & transportation, processing, analysis, and storage. On the basis of utilization, it is categorized in used and unused. Depending on cell type, it is classified into umbilical cord stem cell, cord blood, cord tissue, placenta, adult stem cell, and embryonic stem cell. By bank type, the market is divided into public and private. By age group, the market is mainly categorized into adult and children. By type, it is categorized in brackets, anchorage appliances, ligatures, and arch wires. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include stem cell banking market American CryoStem Corporation, Americord Registry LLC, Cordlife Group Limited, Cordlife Group Limited, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., StemCyte Cord Blood Bank, Covis Pharma., Global Cord Blood Corporation., Smart cells. and CSG BIO.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global stem cell banking market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global stem cell banking market growth.

KEY MARKET SEGMENTS

  • By Service Type
    • Collection & Transportation
    • Processing
    • Analysis
    • Storage
  • By Utilization
    • Used
    • Unused
  • By Cell Type
    • Umbilical Cord Stem Cell
    • Cord Blood
    • Cord Tissue
    • Placenta
    • Adult Stem Cell
    • Embryonic Stem Cell
  • By Bank Type
    • Public
    • Private
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

KEY MARKET PLAYERS

  • American CryoStem Corporation
  • Americord Registry LLC
  • Cordlife Group Limited
  • Cryo Cell International Inc.
  • Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V.
  • StemCyte Cord Blood Bank
  • Covis Pharma.
  • Global Cord Blood Corporation.
  • Smart cells.
  • CSG BIO.
Product Code: LI_184614 / A04261

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1.Report Description
  • 1.2.Key Market Segments
  • 1.3.Key Benefits
  • 1.4.Research Methodology
    • 1.4.1.Primary Research
    • 1.4.2.Secondary Research
    • 1.4.3.Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1.CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1.Market Definition and Scope
  • 3.2.Key Findings
    • 3.2.1.Top Investment Pockets
    • 3.2.2.Top Winning Strategies
  • 3.3.Porter's Five Forces Analysis
    • 3.3.1.Bargaining Power of Suppliers
    • 3.3.2.Threat of New Entrants
    • 3.3.3.Threat of Substitutes
    • 3.3.4.Competitive Rivalry
    • 3.3.5.Bargaining Power among Buyers
  • 3.4.Market Share Analysis/Top Player Positioning
    • 3.4.1.Market Share Analysis/Top Player Positioning 2020
  • 3.5.Market Dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6. COVID-19 Impact Analysis

CHAPTER 4: STEM CELL BANKING MARKET, BY SERVICE TYPE

  • 4.1.Market Overview
  • 4.1.1Market Size and Forecast, By Service Type
  • 4.2.Collection and Transportation
    • 4.2.1.Key Market Trends, Growth Factors and Opportunities
    • 4.2.2.Market Size and Forecast, By Region
    • 4.2.3.Market Share Analysis, By Country
  • 4.3.Processing
    • 4.3.1.Key Market Trends, Growth Factors and Opportunities
    • 4.3.2.Market Size and Forecast, By Region
    • 4.3.3.Market Share Analysis, By Country
  • 4.4.Analysis
    • 4.4.1.Key Market Trends, Growth Factors and Opportunities
    • 4.4.2.Market Size and Forecast, By Region
    • 4.4.3.Market Share Analysis, By Country
  • 4.5.Storage
    • 4.5.1.Key Market Trends, Growth Factors and Opportunities
    • 4.5.2.Market Size and Forecast, By Region
    • 4.5.3.Market Share Analysis, By Country

CHAPTER 5: STEM CELL BANKING MARKET, BY UTILIZATION

  • 5.1.Market Overview
  • 5.1.1Market Size and Forecast, By Utilization
  • 5.2.Used
    • 5.2.1.Key Market Trends, Growth Factors and Opportunities
    • 5.2.2.Market Size and Forecast, By Region
    • 5.2.3.Market Share Analysis, By Country
  • 5.3.UnUsed
    • 5.3.1.Key Market Trends, Growth Factors and Opportunities
    • 5.3.2.Market Size and Forecast, By Region
    • 5.3.3.Market Share Analysis, By Country

CHAPTER 6: STEM CELL BANKING MARKET, BY CELL TYPE

  • 6.1.Market Overview
  • 6.1.1Market Size and Forecast, By Cell Type
  • 6.2.Umbilical Cord Stem Cell
    • 6.2.1.Key Market Trends, Growth Factors and Opportunities
    • 6.2.2.Market Size and Forecast, By Region
    • 6.2.3.Market Share Analysis, By Country
    • 6.2.4.Cord Blood
      • 6.2.4.1.Market Size and Forecast
    • 6.2.5.Cord Tissue
      • 6.2.5.1.Market Size and Forecast
    • 6.2.6.Placenta
      • 6.2.6.1.Market Size and Forecast
  • 6.3.Adult Stem Cell
    • 6.3.1.Key Market Trends, Growth Factors and Opportunities
    • 6.3.2.Market Size and Forecast, By Region
    • 6.3.3.Market Share Analysis, By Country
  • 6.4.Embryonic Stem Cell
    • 6.4.1.Key Market Trends, Growth Factors and Opportunities
    • 6.4.2.Market Size and Forecast, By Region
    • 6.4.3.Market Share Analysis, By Country

CHAPTER 7: STEM CELL BANKING MARKET, BY BANK TYPE

  • 7.1.Market Overview
  • 7.1.1Market Size and Forecast, By Bank Type
  • 7.2.Public
    • 7.2.1.Key Market Trends, Growth Factors and Opportunities
    • 7.2.2.Market Size and Forecast, By Region
    • 7.2.3.Market Share Analysis, By Country
  • 7.3.Private
    • 7.3.1.Key Market Trends, Growth Factors and Opportunities
    • 7.3.2.Market Size and Forecast, By Region
    • 7.3.3.Market Share Analysis, By Country

CHAPTER 8: STEM CELL BANKING MARKET, BY REGION

  • 8.1.Market Overview
  • 8.1.1Market Size and Forecast, By Region
  • 8.2.North America
    • 8.2.1.Key Market Trends and Opportunities
    • 8.2.2.Market Size and Forecast, By Service Type
    • 8.2.3.Market Size and Forecast, By Utilization
    • 8.2.4.Market Size and Forecast, By Cell Type
    • 8.2.5.Market Size and Forecast, By Bank Type
    • 8.2.6.Market Size and Forecast, By Country
    • 8.2.7.United States Stem Cell Banking Market
      • 8.2.7.1.Market Size and Forecast, By Service Type
      • 8.2.7.2.Market Size and Forecast, By Utilization
      • 8.2.7.3.Market Size and Forecast, By Cell Type
      • 8.2.7.4.Market Size and Forecast, By Bank Type
    • 8.2.8.Canada Stem Cell Banking Market
      • 8.2.8.1.Market Size and Forecast, By Service Type
      • 8.2.8.2.Market Size and Forecast, By Utilization
      • 8.2.8.3.Market Size and Forecast, By Cell Type
      • 8.2.8.4.Market Size and Forecast, By Bank Type
    • 8.2.9.Mexico Stem Cell Banking Market
      • 8.2.9.1.Market Size and Forecast, By Service Type
      • 8.2.9.2.Market Size and Forecast, By Utilization
      • 8.2.9.3.Market Size and Forecast, By Cell Type
      • 8.2.9.4.Market Size and Forecast, By Bank Type
  • 8.3.Europe
    • 8.3.1.Key Market Trends and Opportunities
    • 8.3.2.Market Size and Forecast, By Service Type
    • 8.3.3.Market Size and Forecast, By Utilization
    • 8.3.4.Market Size and Forecast, By Cell Type
    • 8.3.5.Market Size and Forecast, By Bank Type
    • 8.3.6.Market Size and Forecast, By Country
    • 8.3.7.France Stem Cell Banking Market
      • 8.3.7.1.Market Size and Forecast, By Service Type
      • 8.3.7.2.Market Size and Forecast, By Utilization
      • 8.3.7.3.Market Size and Forecast, By Cell Type
      • 8.3.7.4.Market Size and Forecast, By Bank Type
    • 8.3.8.Germany Stem Cell Banking Market
      • 8.3.8.1.Market Size and Forecast, By Service Type
      • 8.3.8.2.Market Size and Forecast, By Utilization
      • 8.3.8.3.Market Size and Forecast, By Cell Type
      • 8.3.8.4.Market Size and Forecast, By Bank Type
    • 8.3.9.Italy Stem Cell Banking Market
      • 8.3.9.1.Market Size and Forecast, By Service Type
      • 8.3.9.2.Market Size and Forecast, By Utilization
      • 8.3.9.3.Market Size and Forecast, By Cell Type
      • 8.3.9.4.Market Size and Forecast, By Bank Type
    • 8.3.10.Spain Stem Cell Banking Market
      • 8.3.10.1.Market Size and Forecast, By Service Type
      • 8.3.10.2.Market Size and Forecast, By Utilization
      • 8.3.10.3.Market Size and Forecast, By Cell Type
      • 8.3.10.4.Market Size and Forecast, By Bank Type
    • 8.3.11.U.K Stem Cell Banking Market
      • 8.3.11.1.Market Size and Forecast, By Service Type
      • 8.3.11.2.Market Size and Forecast, By Utilization
      • 8.3.11.3.Market Size and Forecast, By Cell Type
      • 8.3.11.4.Market Size and Forecast, By Bank Type
    • 8.3.12.Rest of Europe Stem Cell Banking Market
      • 8.3.12.1.Market Size and Forecast, By Service Type
      • 8.3.12.2.Market Size and Forecast, By Utilization
      • 8.3.12.3.Market Size and Forecast, By Cell Type
      • 8.3.12.4.Market Size and Forecast, By Bank Type
  • 8.4.Asia-Pacific
    • 8.4.1.Key Market Trends and Opportunities
    • 8.4.2.Market Size and Forecast, By Service Type
    • 8.4.3.Market Size and Forecast, By Utilization
    • 8.4.4.Market Size and Forecast, By Cell Type
    • 8.4.5.Market Size and Forecast, By Bank Type
    • 8.4.6.Market Size and Forecast, By Country
    • 8.4.7.China Stem Cell Banking Market
      • 8.4.7.1.Market Size and Forecast, By Service Type
      • 8.4.7.2.Market Size and Forecast, By Utilization
      • 8.4.7.3.Market Size and Forecast, By Cell Type
      • 8.4.7.4.Market Size and Forecast, By Bank Type
    • 8.4.8.Japan Stem Cell Banking Market
      • 8.4.8.1.Market Size and Forecast, By Service Type
      • 8.4.8.2.Market Size and Forecast, By Utilization
      • 8.4.8.3.Market Size and Forecast, By Cell Type
      • 8.4.8.4.Market Size and Forecast, By Bank Type
    • 8.4.9.India Stem Cell Banking Market
      • 8.4.9.1.Market Size and Forecast, By Service Type
      • 8.4.9.2.Market Size and Forecast, By Utilization
      • 8.4.9.3.Market Size and Forecast, By Cell Type
      • 8.4.9.4.Market Size and Forecast, By Bank Type
    • 8.4.10.South Korea Stem Cell Banking Market
      • 8.4.10.1.Market Size and Forecast, By Service Type
      • 8.4.10.2.Market Size and Forecast, By Utilization
      • 8.4.10.3.Market Size and Forecast, By Cell Type
      • 8.4.10.4.Market Size and Forecast, By Bank Type
    • 8.4.11.Singapore Stem Cell Banking Market
      • 8.4.11.1.Market Size and Forecast, By Service Type
      • 8.4.11.2.Market Size and Forecast, By Utilization
      • 8.4.11.3.Market Size and Forecast, By Cell Type
      • 8.4.11.4.Market Size and Forecast, By Bank Type
    • 8.4.12.Rest of Asia-pacific Stem Cell Banking Market
      • 8.4.12.1.Market Size and Forecast, By Service Type
      • 8.4.12.2.Market Size and Forecast, By Utilization
      • 8.4.12.3.Market Size and Forecast, By Cell Type
      • 8.4.12.4.Market Size and Forecast, By Bank Type
  • 8.5.LAMEA
    • 8.5.1.Key Market Trends and Opportunities
    • 8.5.2.Market Size and Forecast, By Service Type
    • 8.5.3.Market Size and Forecast, By Utilization
    • 8.5.4.Market Size and Forecast, By Cell Type
    • 8.5.5.Market Size and Forecast, By Bank Type
    • 8.5.6.Market Size and Forecast, By Country
    • 8.5.7.Brazil Stem Cell Banking Market
      • 8.5.7.1.Market Size and Forecast, By Service Type
      • 8.5.7.2.Market Size and Forecast, By Utilization
      • 8.5.7.3.Market Size and Forecast, By Cell Type
      • 8.5.7.4.Market Size and Forecast, By Bank Type
    • 8.5.8.South Africa, Stem Cell Banking Market
      • 8.5.8.1.Market Size and Forecast, By Service Type
      • 8.5.8.2.Market Size and Forecast, By Utilization
      • 8.5.8.3.Market Size and Forecast, By Cell Type
      • 8.5.8.4.Market Size and Forecast, By Bank Type
    • 8.5.9.Saudi Arabia Stem Cell Banking Market
      • 8.5.9.1.Market Size and Forecast, By Service Type
      • 8.5.9.2.Market Size and Forecast, By Utilization
      • 8.5.9.3.Market Size and Forecast, By Cell Type
      • 8.5.9.4.Market Size and Forecast, By Bank Type
    • 8.5.10.Rest of LAMEA Stem Cell Banking Market
      • 8.5.10.1.Market Size and Forecast, By Service Type
      • 8.5.10.2.Market Size and Forecast, By Utilization
      • 8.5.10.3.Market Size and Forecast, By Cell Type
      • 8.5.10.4.Market Size and Forecast, By Bank Type

CHAPTER 9: COMPANY PROFILES

  • 9.1.American CryoStem Corporation
    • 9.1.1.Company Overview
    • 9.1.2.Key Executives
    • 9.1.3.Company snapshot
    • 9.1.4.Operating business segments
    • 9.1.5.Product portfolio
    • 9.1.6.Business Performance
    • 9.1.7.Key Strategic Moves and Developments
  • 9.2.Americord Registry LLC
    • 9.2.1.Company Overview
    • 9.2.2.Key Executives
    • 9.2.3.Company snapshot
    • 9.2.4.Operating business segments
    • 9.2.5.Product portfolio
    • 9.2.6.Business Performance
    • 9.2.7.Key Strategic Moves and Developments
  • 9.3.Cordlife Group Limited
    • 9.3.1.Company Overview
    • 9.3.2.Key Executives
    • 9.3.3.Company snapshot
    • 9.3.4.Operating business segments
    • 9.3.5.Product portfolio
    • 9.3.6.Business Performance
    • 9.3.7.Key Strategic Moves and Developments
  • 9.4.Cryo Cell International Inc.
    • 9.4.1.Company Overview
    • 9.4.2.Key Executives
    • 9.4.3.Company snapshot
    • 9.4.4.Operating business segments
    • 9.4.5.Product portfolio
    • 9.4.6.Business Performance
    • 9.4.7.Key Strategic Moves and Developments
  • 9.5.Cryoholdco De LatinoAmerica
    • 9.5.1.Company Overview
    • 9.5.2.Key Executives
    • 9.5.3.Company snapshot
    • 9.5.4.Operating business segments
    • 9.5.5.Product portfolio
    • 9.5.6.Business Performance
    • 9.5.7.Key Strategic Moves and Developments
  • 9.6.StemCyte Cord Blood Bank
    • 9.6.1.Company Overview
    • 9.6.2.Key Executives
    • 9.6.3.Company snapshot
    • 9.6.4.Operating business segments
    • 9.6.5.Product portfolio
    • 9.6.6.Business Performance
    • 9.6.7.Key Strategic Moves and Developments
  • 9.7.Covis Pharma
    • 9.7.1.Company Overview
    • 9.7.2.Key Executives
    • 9.7.3.Company snapshot
    • 9.7.4.Operating business segments
    • 9.7.5.Product portfolio
    • 9.7.6.Business Performance
    • 9.7.7.Key Strategic Moves and Developments
  • 9.8.Global Cord Blood Corporation
    • 9.8.1.Company Overview
    • 9.8.2.Key Executives
    • 9.8.3.Company snapshot
    • 9.8.4.Operating business segments
    • 9.8.5.Product portfolio
    • 9.8.6.Business Performance
    • 9.8.7.Key Strategic Moves and Developments
  • 9.9.Smart Cells
    • 9.9.1.Company Overview
    • 9.9.2.Key Executives
    • 9.9.3.Company snapshot
    • 9.9.4.Operating business segments
    • 9.9.5.Product portfolio
    • 9.9.6.Business Performance
    • 9.9.7.Key Strategic Moves and Developments
  • 9.10.CSG BIO
    • 9.10.1.Company Overview
    • 9.10.2.Key Executives
    • 9.10.3.Company snapshot
    • 9.10.4.Operating business segments
    • 9.10.5.Product portfolio
    • 9.10.6.Business Performance
    • 9.10.7.Key Strategic Moves and Developments

LIST OF TABLES

  • TABLE 1.GLOBAL STEM CELL BANKING MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 2.GLOBAL STEM CELL BANKING MARKET FOR COLLECTION AND TRANSPORTATION, BY REGION, 2020-2030 ($MILLION)
  • TABLE 3.GLOBAL STEM CELL BANKING MARKET FOR PROCESSING, BY REGION, 2020-2030 ($MILLION)
  • TABLE 4.GLOBAL STEM CELL BANKING MARKET FOR ANALYSIS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 5.GLOBAL STEM CELL BANKING MARKET FOR STORAGE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 6.GLOBAL STEM CELL BANKING MARKET, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 7.GLOBAL STEM CELL BANKING MARKET FOR USED, BY REGION, 2020-2030 ($MILLION)
  • TABLE 8.GLOBAL STEM CELL BANKING MARKET FOR USED, BY REGION, 2020-2030 ($MILLION)
  • TABLE 9.GLOBAL STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 10.GLOBAL STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELL, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.GLOBAL STEM CELL BANKING MARKET FOR ADULT STEM CELL, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.GLOBAL STEM CELL BANKING MARKET FOR EMBRYONIC STEM CELL, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 14.GLOBAL STEM CELL BANKING MARKET FOR PUBLIC, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.GLOBAL STEM CELL BANKING MARKET FOR PRIVATE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.GLOBAL STEM CELL BANKING MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 17.NORTH AMERICA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 20.NORTH AMERICA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 21.UNITED STATES STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 22.UNITED STATES STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 23.UNITED STATES STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 24.UNITED STATES STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 25.CANADA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 26.CANADA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 27.CANADA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 28.CANADA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 29.MEXICO STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 30.MEXICO STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 31.MEXICO STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 32.MEXICO STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 33.EUROPE STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 34.EUROPE STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 35.EUROPE STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 36.EUROPE STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 37.FRANCE STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 38.FRANCE STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 39.FRANCE STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 40.FRANCE STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 41.GERMANY STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 42.GERMANY STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 43.GERMANY STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 44.GERMANY STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 45.ITALY STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 46.ITALY STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 47.ITALY STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 48.ITALY STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 49.SPAIN STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 50.SPAIN STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 51.SPAIN STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 52.SPAIN STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 53.UNITED KINGDOM STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 54.UNITED KINGDOM STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 55.UNITED KINGDOM STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 56.UNITED KINGDOM STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 57.REST OF EUROPE STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 58.REST OF EUROPE STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 59.REST OF EUROPE STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 60.REST OF EUROPE STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 61.ASIA-PACIFIC STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 62.ASIA-PACIFIC STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 63.ASIA-PACIFIC STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 64.ASIA-PACIFIC STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 65.CHINA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 66.CHINA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 67.CHINA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 68.CHINA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 69.JAPAN STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 70.JAPAN STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 71.JAPAN STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 72.JAPAN STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 73.INDIA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 74.INDIA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 75.INDIA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 76.INDIA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 77.SOUTH KOREA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 78.SOUTH KOREA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 79.SOUTH KOREA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 80.SOUTH KOREA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 81.SINGAPORE STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 82.SINGAPORE STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 83.SINGAPORE STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 84.SINGAPORE STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 85.REST OF ASIA-PACIFIC STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 86.REST OF ASIA-PACIFIC STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 87.REST OF ASIA-PACIFIC STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 88.REST OF ASIA-PACIFIC STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 89.LAMEA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 90.LAMEA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 91.LAMEA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 92.LAMEA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 93.BRAZIL STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 94.BRAZIL STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 95.BRAZIL STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 96.BRAZIL STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 97.SOUTH AFRICA, STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 98.SOUTH AFRICA, STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 99.SOUTH AFRICA, STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 100.SOUTH AFRICA, STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 101.SAUDI ARABIA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 102.SAUDI ARABIA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 103.SAUDI ARABIA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 104.SAUDI ARABIA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 105.REST OF LAMEA STEM CELL BANKING, BY SERVICE TYPE, 2020-2030 ($MILLION)
  • TABLE 106.REST OF LAMEA STEM CELL BANKING, BY UTILIZATION, 2020-2030 ($MILLION)
  • TABLE 107.REST OF LAMEA STEM CELL BANKING, BY CELL TYPE, 2020-2030 ($MILLION)
  • TABLE 108.REST OF LAMEA STEM CELL BANKING, BY BANK TYPE, 2020-2030 ($MILLION)
  • TABLE 109.AMERICAN CRYOSTEM CORPORATION: KEY EXECUTIVES
  • TABLE 110.AMERICAN CRYOSTEM CORPORATION: COMPANY SNAPSHOT
  • TABLE 111.AMERICAN CRYOSTEM CORPORATION: OPERATING SEGMENTS
  • TABLE 112.AMERICAN CRYOSTEM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 113.AMERICAN CRYOSTEM CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114.AMERICORD REGISTRY LLC: KEY EXECUTIVES
  • TABLE 115.AMERICORD REGISTRY LLC: COMPANY SNAPSHOT
  • TABLE 116.AMERICORD REGISTRY LLC: OPERATING SEGMENTS
  • TABLE 117.AMERICORD REGISTRY LLC: PRODUCT PORTFOLIO
  • TABLE 118.AMERICORD REGISTRY LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119.CORDLIFE GROUP LIMITED: KEY EXECUTIVES
  • TABLE 120.CORDLIFE GROUP LIMITED: COMPANY SNAPSHOT
  • TABLE 121.CORDLIFE GROUP LIMITED: OPERATING SEGMENTS
  • TABLE 122.CORDLIFE GROUP LIMITED: PRODUCT PORTFOLIO
  • TABLE 123.CORDLIFE GROUP LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124.CRYO CELL INTERNATIONAL INC: KEY EXECUTIVES
  • TABLE 125.CRYO CELL INTERNATIONAL INC: COMPANY SNAPSHOT
  • TABLE 126.CRYO CELL INTERNATIONAL INC: OPERATING SEGMENTS
  • TABLE 127.CRYO CELL INTERNATIONAL INC: PRODUCT PORTFOLIO
  • TABLE 128.CRYO CELL INTERNATIONAL INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129.CRYOHOLDCO DE LATINOAMERICA: KEY EXECUTIVES
  • TABLE 130.CRYOHOLDCO DE LATINOAMERICA: COMPANY SNAPSHOT
  • TABLE 131.CRYOHOLDCO DE LATINOAMERICA: OPERATING SEGMENTS
  • TABLE 132.CRYOHOLDCO DE LATINOAMERICA: PRODUCT PORTFOLIO
  • TABLE 133.CRYOHOLDCO DE LATINOAMERICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134.STEMCYTE CORD BLOOD BANK: KEY EXECUTIVES
  • TABLE 135.STEMCYTE CORD BLOOD BANK: COMPANY SNAPSHOT
  • TABLE 136.STEMCYTE CORD BLOOD BANK: OPERATING SEGMENTS
  • TABLE 137.STEMCYTE CORD BLOOD BANK: PRODUCT PORTFOLIO
  • TABLE 138.STEMCYTE CORD BLOOD BANK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139.COVIS PHARMA: KEY EXECUTIVES
  • TABLE 140.COVIS PHARMA: COMPANY SNAPSHOT
  • TABLE 141.COVIS PHARMA: OPERATING SEGMENTS
  • TABLE 142.COVIS PHARMA: PRODUCT PORTFOLIO
  • TABLE 143.COVIS PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144.GLOBAL CORD BLOOD CORPORATION: KEY EXECUTIVES
  • TABLE 145.GLOBAL CORD BLOOD CORPORATION: COMPANY SNAPSHOT
  • TABLE 146.GLOBAL CORD BLOOD CORPORATION: OPERATING SEGMENTS
  • TABLE 147.GLOBAL CORD BLOOD CORPORATION: PRODUCT PORTFOLIO
  • TABLE 148.GLOBAL CORD BLOOD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149.SMART CELLS: KEY EXECUTIVES
  • TABLE 150.SMART CELLS: COMPANY SNAPSHOT
  • TABLE 151.SMART CELLS: OPERATING SEGMENTS
  • TABLE 152.SMART CELLS: PRODUCT PORTFOLIO
  • TABLE 153.SMART CELLS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154.CSG BIO: KEY EXECUTIVES
  • TABLE 155.CSG BIO: COMPANY SNAPSHOT
  • TABLE 156.CSG BIO: OPERATING SEGMENTS
  • TABLE 157.CSG BIO: PRODUCT PORTFOLIO
  • TABLE 158.CSG BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1.GLOBAL STEM CELL BANKING MARKET SEGMENTATION
  • FIGURE 2.GLOBAL STEM CELL BANKING MARKET
  • FIGURE 3.SEGMENTATION STEM CELL BANKING MARKET
  • FIGURE 4.TOP INVESTMENT POCKET IN STEM CELL BANKING MARKET
  • FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
  • FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
  • FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
  • FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 11.LOW THREAT OF SUBSTITUTION
  • FIGURE 12.HIGH COMPETITIVE RIVALRY
  • FIGURE 13.TOP PLAYER POSITIONING, 2020
  • FIGURE 14.MARKET SHARE ANALYSIS, 2020
  • FIGURE 15.RESTRAINTS AND DRIVERS: STEM CELL BANKING MARKET
  • FIGURE 16.STEM CELL BANKING MARKET SEGMENTATION, BY SERVICE TYPE
  • FIGURE 17.STEM CELL BANKING MARKET FOR COLLECTION AND TRANSPORTATION, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 18.STEM CELL BANKING MARKET FOR PROCESSING, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 19.STEM CELL BANKING MARKET FOR ANALYSIS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 20.STEM CELL BANKING MARKET FOR STORAGE, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 21.STEM CELL BANKING MARKET SEGMENTATION, BY UTILIZATION
  • FIGURE 22.STEM CELL BANKING MARKET FOR USED, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 23.STEM CELL BANKING MARKET FOR USED, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 24.STEM CELL BANKING MARKET SEGMENTATION, BY CELL TYPE
  • FIGURE 25.STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELL, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 26.STEM CELL BANKING MARKET FOR ADULT STEM CELL, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 27.STEM CELL BANKING MARKET FOR EMBRYONIC STEM CELL, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 28.STEM CELL BANKING MARKET SEGMENTATION, BY BANK TYPE
  • FIGURE 29.STEM CELL BANKING MARKET FOR PUBLIC, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 30.STEM CELL BANKING MARKET FOR PRIVATE, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 31.AMERICAN CRYOSTEM CORPORATION: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 32.AMERICAN CRYOSTEM CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 33.AMERICAN CRYOSTEM CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 34.AMERICORD REGISTRY LLC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.AMERICORD REGISTRY LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 36.AMERICORD REGISTRY LLC: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 37.CORDLIFE GROUP LIMITED: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.CORDLIFE GROUP LIMITED: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 39.CORDLIFE GROUP LIMITED: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 40.CRYO CELL INTERNATIONAL INC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.CRYO CELL INTERNATIONAL INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 42.CRYO CELL INTERNATIONAL INC: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 43.CRYOHOLDCO DE LATINOAMERICA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.CRYOHOLDCO DE LATINOAMERICA: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 45.CRYOHOLDCO DE LATINOAMERICA: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 46.STEMCYTE CORD BLOOD BANK: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 47.STEMCYTE CORD BLOOD BANK: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 48.STEMCYTE CORD BLOOD BANK: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 49.COVIS PHARMA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 50.COVIS PHARMA: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 51.COVIS PHARMA: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 52.GLOBAL CORD BLOOD CORPORATION: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 53.GLOBAL CORD BLOOD CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 54.GLOBAL CORD BLOOD CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 55.SMART CELLS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 56.SMART CELLS: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 57.SMART CELLS: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 58.CSG BIO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 59.CSG BIO: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 60.CSG BIO: REVENUE SHARE, BY REGION, 2020 (%)